A class of novel aminotetralins is disclosed useful as 5-HT1D&agr; agonists.
一类新型氨基四环烯被披露为5-HT1D&agr;激动剂。
Aminotetralins as 5-HT1Dalpha agonists
申请人:——
公开号:US20020065312A1
公开(公告)日:2002-05-30
A class of novel aminotetralins is disclosed useful as 5-HT
1D&agr;
agonists.
公开了一类新型氨基四氢萘作为 5-HT
1D&agr;
激动剂。
[EN] AMINOTETRALINS AS 5-HT1D alpha AGONISTS<br/>[FR] AMINOTETRALINES SERVANT D'AGONISTES DE 5-HT1D alpha
申请人:ELI LILLY AND COMPANY
公开号:WO1998048786A1
公开(公告)日:1998-11-05
(EN) A class of novel aminotetralins is disclosed useful as 5-HT1D$g(a) agonists.(FR) La présente invention concerne une classe d'aminotétralines convenant comme agonistes de 5-HT1D$g(a).
一种新型氨基四氢萘类化合物被披露,可用作5-HT1D\(_a}\)激动剂。
6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase
作者:Jing Tang、Kasthuraiah Maddali、Christine D. Dreis、Yuk Y. Sham、Robert Vince、Yves Pommier、Zhengqiang Wang
DOI:10.1016/j.bmcl.2011.02.069
日期:2011.4
N-3-Hydroxylation of pyrimidine-2,4-diones was recently found to yield inhibitors of both HIV-1 reverse transcriptase (RT) and integrase (IN). An extended series of analogues featuring a benzoyl group at the C-6 position of the pyrimidine ring was synthesized. Through biochemical studies it was found that these new analogues are dually active against both RT and IN in low micromolar range. Antiviral assays confirmed that these new inhibitors are active against HIV-1 in cell culture at nanomolar to low micromolar range, further validating 3-hydroxypyrimidine-2,4-diones as a viable scaffold for antiviral development. (C) 2011 Elsevier Ltd. All rights reserved.